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LETTERS TO THE EDITOR 
Ioxaglate, Iopamidol and Diatrizoate in 
Coronary Arteriography 
Gertz et al. (1) made reference to the animal study done by Tra•
gardh and Lynch (2). It should be pointed out that the ioxaglate 
formulation used in this study was an experimental compound that 
contained 255 mEq/liter of sodium. The ioxagJ.ate formulation 
currently being marketed in Canada and Europe and under inves•
tigation in the United States (Hexabrix) contains a physiologic 
concentration of sodium (150 mEq/liter). Further, it should be 
noted that in blind clinical studies in humans when Hexabrix was 
compared with either iopamidol or iohexol, there was a tendency 
for Hexabrix to cause the least hemodynamic effect (3,4) during 
coronary angiography. 
THOMAS W. TUSING, MD 
Mallinckrodt, Inc. 
St. Louis, Missouri 63134 
References 
I. Gertz EW, Wisneski JA, Chiu D, Akin JR, Hu e. Clinical superiority of a new 
nonionic contrast agent (iopamidol) for cardiac angiography. J Am Coli Cardiol 
1985;5:250--8. 
2. Tragardh B, Lynch PRo Cardiac function during left coronary arteriography in 
canines with ioxaglate, nohionic compounds, and diatrizoate. Invest Radiol 
1980;15:449-51. 
3. Weikl A, Hubmann A. A survey of contrast media used in coronary angiography. 
Cardiovasc Intervent Radiol 1982;5:202-10. 
4. Cumberland D. Low·osmolality contrast media in cardiac radiology. Invest Radiol 
1984;19 (suppl 6):S30l-5. 
Reply 
We are aware of and have read the two references (1,2) Tusing 
cites. Neither report mentions that the protocols were either single•
or double-blind. Weikl et al. (1) studied two groups of 20 patients. 
One group received diatrizoate and ioxaglate (Hexabrix); the other, 
diatrizoate and iopainidol. Both groups received the contrast agent 
in a random order. No data are presented as a comparison between 
iopamidol and Hexabrix. The study by Cumberland (2) coinpared 
meglumine diatrizoate, iohexol and Hexabrlx In the same 25 pa•
tients. The contrast agents were given in a random order. The 
conclusion froin this study was that there was no statistical dif•
ference between iohexol and Hexabrix regarding hemodynamic or 
heart rate changes after coronary artery injection. 
Since both of these studies contained small patient numbers 
with two or three contrast agents injected into the same patient 
over a short period of time, the conclusions may not be valid. We 
have previously shown that the metabolic effects of one injection 
of Renografin-76 into the coronary artery produces myocardial 
metabolic effects for at least 20 minutes (3). Compounding these 
metabolic changes with multiple injections of different agents in 
a short time period could affect any study. A large randomized, 
double-blind comparison of the non ionic contrast agents and low 
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osmolality Ionic agents is justified. We have attempted to obtain 
Hexabrix from Mallinckrodt, Inc. to perform such a study, but so 
far have been unsuccessful. 
EDWARD W. GERTZ, MD, FACC 
JUDITH A. WISNESKI, MD, FACC 
Veterans Administration Medical Center (I] IC]) 
4]50 Clement Street 
San Francisco, California 94121 
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Aneurysm of the Interatrial Septum 
Wyshain et al. (1) reported on a 23 year old woman with mitral 
valve prolapse and an aneurysm of the interatrial septum. The 
association of atrioventricular (A V) valve prolapse and aneurysm 
of the interatrial septum has been recently recognized (2,3). We 
(4) described a newborn with an aneurysm of the interatrial septum 
and a small atrial septal defect. The mitral valve was normal and 
there was no evidence of prolapse. The patient was last evaluated 
at age 3 years. No cardiac murmurs or clicks were noted. The 
chest radiograph and electrocardiogram were normal. Two-di•
mensional echocardiographic examination demonstrated persis•
tence of the interatrial septal aneurysm and the atrial septal defect. 
No A V valve prolapse was noted. Because A V valve prolapse has 
been described in patients with interatrial septal aneurysms, these 
patients should be followed up for the development of prolapse. 
Only long-term follow-up studies will determine if the association 
of A V valve prolapse and interatrial septal aneurysm is coincidental 
or related to a deficiency of the endocardium as suggested by 
Roberts (3). 
ALFONSO CASTA, MD, FACC 
Division of Cardiology 
Department of Pediatrics 
University of Texas Medical Branch 
Galveston, Texas 77550 
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